DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 1 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 470,000 | $1,212,600 | 3.97% |
| Altium Capital Management LP | 496,000 | $1,279,680 | 0.67% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 168,730 | $435,323 | 0.61% |
| Bleichroeder LP | 222,317 | $573,578 | 0.14% |
| Aristides Capital LLC | 106,333 | $274,339 | 0.12% |
| COOPERMAN LEON G | 875,993 | $2,260,062 | 0.12% |
| EAM Investors, LLC | 212,512 | $548,281 | 0.11% |
| CATALYST FINANCIAL PARTNERS LLC | 36,267 | $93,569 | 0.03% |
| Stonebridge Capital Advisors LLC | 20,000 | $51,600 | 0.01% |
| Legend Financial Advisors, Inc. | 1,000 | $2,580 | 0.00% |